FridayMar 22, 2024 10:00 am

Gene Signature Could Predict NSC Lung Cancer Response to Immunotherapy

New research has found genes that could help forecast how non-small cell lung cancer may respond to a treatment combination of low-dose radiation and immunotherapy. The researchers explained that these genes could help identify tumors that were more likely to be destroyed by immunotherapies. Immunotherapies work by activating an individual’s immune system to fight the cancer. Despite saving numerous lives, however, only about 25% of patients respond to it. Being able to predict who could benefit from this new discovery and the underlying mechanism of action would greatly benefit patients who gain no benefit from other modes of treatment. For…

Continue Reading

ThursdayMar 21, 2024 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) Developing Pipeline to Address Unmet Needs in Autism Spectrum Disorder via Suramin Sodium

Autism (“ASD”) is a global problem, with no generally accepted treatment. In the UK alone, between 1998 and 2018, research has found a greater than 780% increase in the number of autism cases PaxMedica is focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of ASD and other serious conditions with intractable neurologic symptoms The ASD therapeutics market was valued at $2.01 billion in 2023 and is expected to reach $3.42 billion by 2030, growing at a CAGR of 7.9% There is currently no approved pharmacologic treatment targeting the cause and symptoms. Current treatments only address the…

Continue Reading

WednesdayMar 20, 2024 11:00 am

How AI Can Help in Crafting Memorable eCommerce Experiences

The emergence of incredibly advanced artificial intelligence (AI)-powered tools in recent years has provided e-commerce businesses with an effective tool for creating memorable customer experiences. A growing number of consumers are buying goods online, thanks to the convenience, variety, better prices and safety offered by online marketplaces. Evolving consumer behavior in the wake of coronavirus-related lockdowns has also contributed to the increase in online shopping. With more businesses worldwide opening online stores, competition in the e-commerce space is heating up fast. Consequently, providing customers with a memorable and enjoyable shopping experience will be key for online retailers who want to…

Continue Reading

MondayMar 18, 2024 10:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors

CNS Pharmaceuticals recently appointed Amy Mahery, a biotech commercialization leader, to its Board of Directors Ms. Mahery brings over 20 years’ experience, having worked with small and large companies, and has held diverse commercial leadership roles in the U.S. and globally The company believes Ms. Mahery’s guidance, insight, and vast pharma industry network will indeed be invaluable as the company advances Berubicin, its flagship drug candidate, toward completion of its global potentially pivotal clinical trial and potential regulatory approval The company recently completed the enrollment of patients in its potentially pivotal global clinical trial Ms. Mahery believes Berubicin represents an…

Continue Reading

MondayMar 18, 2024 10:30 am

New Research Sheds Light on the Initial Stages of Brain Cancer Development

Recent research has identified processes that could lead to the growth of tumors. The research was conducted by a team at the University of Plymouth’s Brain Tumour Research Centre, led by Dr. Claudia Barros. This institution is focused on providing new understanding of certain groups of common, low-grade brain tumors. For their research, the investigators used Drosophila fruit flies. This allowed them to identify changes that could play a role in a healthy cell becoming a cancerous one in the brain. Once this was done, investigators translated their discovery using glioma cells. Glioma is a tumor commonly found in the…

Continue Reading

FridayMar 15, 2024 11:00 am

New AI Model Can Detect Diseases by Analyzing Visual Maps

New research has facilitated the development of an artificial intelligence model that can detect illnesses by examining medical images. This model can accurately pick out tumors and provide reasons for every diagnosis given via visual maps. This tool’s development marks an important advancement in the healthcare technology field, because it will simplify the process of detecting illnesses as well as the diagnosis process. The study was led by Beckman Institute graduate research assistant Sourya Sengupta, who highlighted that the study’s focus was on detecting cancer in its early stages. The visual maps produced by the model, dubbed equivalency maps, are…

Continue Reading

WednesdayMar 13, 2024 10:15 am

Medicare Physician Pay Reduction Renews Calls for System Overhaul

Congress has once again failed to halt a physician pay cut that will affect access to high-quality care by patients on Medicare. In a recently struck deal, the House voted to decrease this year’s proposed pay-cut for physicians by half, with the Senate expected to vote on the same measure. The need to reform physician payment is dire, with the American Medical Association (AMA) showing that the system in use at the moment is unsustainable. This comes after Medicare physicians received a 2% reduction in their pay in 2023.  In a statement, Jesse M. Ehrenfeld, president of the American Medical…

Continue Reading

MondayMar 11, 2024 10:45 am

Rheumatoid Arthritis Patients Face Heightened Risk of Depression, Study Finds

Recently published data shows that rheumatoid arthritis patients have a heightened risk for developing depression. This study is the first to investigate the link between rheumatoid arthritis and the risk of developing depression. The researchers’ objective was to examine the effect of anticyclic citrullinated peptide and rheumatoid factor antibodies on depression in patients with rheumatoid arthritis and find data on the effect of DMARD prescriptions on rheumatoid arthritis-associated depression. These antibodies serve as markers of illness severity and offer insights into the risk of comorbidity. On the other hand, DMARD prescriptions are often given with other drugs such as NSAIDs…

Continue Reading

MondayMar 11, 2024 10:30 am

Astiva Health Inc. — Pioneering a New Era in Aging Healthcare

Astiva Health is revolutionizing patient involvement in healthcare, particularly for the aging population Beyond offering healthcare services, Astiva is dedicated to creating a supportive health community With patients at the center, Astiva Health is transforming aging healthcare into a proactive, participatory experience The United States is in the midst of a global demographic shift toward an aging population, with the U.S. Census Bureau projecting that by 2034, adults aged 65 and older will outnumber children under the age of 18 for the first time in U.S. history (https://ibn.fm/yGoyH). With this shift, the demand for a more holistic approach to healthcare…

Continue Reading

FridayMar 08, 2024 11:00 am

Rising Cases of Autism in UK Raise Concerns

Decades ago, researchers believed that autism disoder affected one in every 2,500 kids. Today, it is estimated that one in 36 kids have the disorder. Autism spectrum disorder is a developmental disorder that affects how an individual interacts with other people, behaves, communicates and learns. While this disorder can be diagnosed at any age, symptoms often appear in the first two years of life. Research has found that between 1998 and 2018, there has been a more than 780% increase in the number of autism cases in the United Kingdom. This significant increase is partly because of a deeper understanding…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050